{"title":"A Case Series of Chronic Spontaneous Urticaria After COVID-19 Vaccination.","authors":"Jeong-Hee Choi, Soo Jie Chung","doi":"10.4168/aair.2023.15.5.695","DOIUrl":null,"url":null,"abstract":"Coronavirus disease 2019 (COVID-19) vaccines play an important role in overcoming the global COVID-19 pandemic. Various immediate or delayed types of cutaneous adverse reactions, such as local site reactions, urticaria, mobilliform rashes, and delayed large local reactions, have been noted after COVID-19 vaccination, which are usually treatable with time.1,2 Chronic spontaneous urticaria (CSU) is defined by recurrent hives lasting > 6 weeks.3 Some patients have developed CSU after COVID-19 vaccination.4-6 Here, we report 12 patients with CSU after COVID-19 vaccination in Korea. We describe the clinical characteristics, treatment, and prognosis of these patients.","PeriodicalId":7547,"journal":{"name":"Allergy, Asthma & Immunology Research","volume":"15 5","pages":"695-698"},"PeriodicalIF":4.1000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/84/c2/aair-15-695.PMC10570777.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergy, Asthma & Immunology Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4168/aair.2023.15.5.695","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/26 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
Coronavirus disease 2019 (COVID-19) vaccines play an important role in overcoming the global COVID-19 pandemic. Various immediate or delayed types of cutaneous adverse reactions, such as local site reactions, urticaria, mobilliform rashes, and delayed large local reactions, have been noted after COVID-19 vaccination, which are usually treatable with time.1,2 Chronic spontaneous urticaria (CSU) is defined by recurrent hives lasting > 6 weeks.3 Some patients have developed CSU after COVID-19 vaccination.4-6 Here, we report 12 patients with CSU after COVID-19 vaccination in Korea. We describe the clinical characteristics, treatment, and prognosis of these patients.
期刊介绍：
The journal features cutting-edge original research, brief communications, and state-of-the-art reviews in the specialties of allergy, asthma, and immunology, including clinical and experimental studies and instructive case reports. Contemporary reviews summarize information on topics for researchers and physicians in the fields of allergy and immunology. As of January 2017, AAIR do not accept case reports. However, if it is a clinically important case, authors can submit it in the form of letter to the Editor. Editorials and letters to the Editor explore controversial issues and encourage further discussion among physicians dealing with allergy, immunology, pediatric respirology, and related medical fields. AAIR also features topics in practice and management and recent advances in equipment and techniques for clinicians concerned with clinical manifestations of allergies and pediatric respiratory diseases.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
